Henri Bismuth

Active 1974–2024

123
Papers
30,675
Citations
98
h-index
123
i10-index

Citations

Citations per year for Henri Bismuth1975: 1 citations1978: 1 citations1979: 2 citations1981: 1 citations1982: 5 citations1983: 4 citations1984: 4 citations1985: 9 citations1986: 11 citations1987: 9 citations1988: 20 citations1989: 28 citations1990: 26 citations1991: 38 citations1992: 46 citations1993: 58 citations1994: 75 citations1995: 112 citations1996: 112 citations1997: 103 citations1998: 175 citations1999: 160 citations2000: 218 citations2001: 202 citations2002: 234 citations2003: 287 citations2004: 249 citations2005: 262 citations2006: 300 citations2007: 310 citations2008: 287 citations2009: 248 citations2010: 221 citations2011: 194 citations2012: 201 citations2013: 184 citations2014: 152 citations2015: 118 citations2016: 103 citations2017: 80 citations2018: 52 citations2019: 353 citations2020: 318 citations2021: 300 citations2022: 187 citations2023: 116 citations2024: 196 citations2025: 55 citations2026: 2 citations1976–1977: no citations, so these years are not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,693 citing papers, 23.6% of this breakdownFrance: 726 citing papers, 10.1% of this breakdownItaly: 508 citing papers, 7.1% of this breakdownUnited Kingdom: 481 citing papers, 6.7% of this breakdownChina: 433 citing papers, 6% of this breakdownJapan: 433 citing papers, 6% of this breakdownGermany: 412 citing papers, 5.7% of this breakdownSpain: 267 citing papers, 3.7% of this breakdownNetherlands: 242 citing papers, 3.4% of this breakdownCanada: 198 citing papers, 2.7% of this breakdownSwitzerland: 164 citing papers, 2.3% of this breakdownBelgium: 143 citing papers, 2% of this breakdown
0%23.6%Other 20.7%

Fields

  • Medicine93.6%
  • Biochemistry, Genetics and Molecular Biology2.4%
  • Neuroscience1.3%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Immunology and Microbiology0.5%
  • Engineering0.4%
  • Other1%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis14.8%
  • Organ Transplantation Techniques and Outcomes9.3%
  • Liver Disease and Transplantation7.6%
  • Cholangiocarcinoma and Gallbladder Cancer Studies7.5%
  • Liver Disease Diagnosis and Treatment6.4%
  • Hepatitis C virus research4.1%
  • Other50.3%

Coauthors

All papers

Open in search
  1. Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy

    Authors: , , , , , , , , , , , - Annals of Surgery 2004 cited by 1,474

  2. Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors?

    Authors: , , , , , , , , , - The Oncologist 2016 cited by 154

  3. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?

    Authors: , , , , , , , , , , , - Journal of Hepatology 2015 cited by 142

  4. Defining Major Surgery: A Delphi Consensus Among European Surgical Association (ESA) Members

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bertil Hamberger, J.F. Hamming, A. H. Hölscher, Jakob R. Izbicki, Sven Jonas, Aleksandar Karamarković, Henrik Kehlet, Ari Leppäniemi, Jan Lerut, Pål‐Dag Line, J. Peter A. Lodge, Jonathan Meakins, Marco Montorsi, Philippe Nafteux, Peter Naredi, Attila Oláh, Yves Panís, Fernando Pardo, Rowan W. Parks, Sergio Pedrazzoli, Patrick Pessaux, Hugo P. Marques, Gilberto Poggioli, Irinel Popescu, Pauli Puolakkainen, José Manuel Ramia, Jari Räsänen, John V. Reynolds, Riccardo Rosati, Hans‐Detlev Saeger, Stefan Schneeberger, Paul M. Schneider, Kjetil Søreide, Dirk L. Stippel, Christian Toso, Jean–Jacques Tuech, Erkki Tukiainen, Richard van Hillegersberg, Bas P. L. Wijnhoven, Desmond C. Winter, Giovanni Zaninotto - World Journal of Surgery 2020 cited by 91

  5. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , - Annals of Surgical Oncology 2019 cited by 67

  6. Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 587

  7. Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved

    Authors: , , , , , , , , , , - Liver Transplantation 2017 cited by 137

  8. Surgical anatomy and anatomical surgery of the liver

    Authors: - World Journal of Surgery 1982 cited by 795

  9. Management Strategies in Resection for Hilar Cholangiocarcinoma

    Authors: , , - Annals of Surgery 1992 cited by 803

  10. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

    Authors: , - 1975 cited by 752

  11. Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial

    Authors: , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 1994 cited by 396

  12. Percutaneous Portal Vein Embolization Increases the Feasibility and Safety of Major Liver Resection for Hepatocellular Carcinoma in Injured Liver

    Authors: , , , , , , , - Annals of Surgery 2000 cited by 393

  13. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

    Authors: , , , , , , , , , , , , - Cancer 1992 cited by 338

  14. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients

    Authors: , , , , , , , , , , , , , - Liver Transplantation 2001 cited by 280

  15. Tumor Progression While on Chemotherapy

    Authors: , , , , , , , - Annals of Surgery 2004 cited by 999

  16. Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors

    Authors: , , , , - Annals of Surgery 2000 cited by 796

  17. Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor

    Authors: , , , , , , , , , - American Journal of Transplantation 2009 cited by 245

  18. Posthepatectomy Portal Vein Pressure Predicts Liver Failure and Mortality after Major Liver Resection on Noncirrhotic Liver

    Authors: , , , , , , , - Annals of Surgery 2013 cited by 142

  19. Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on Cirrhosis

    Authors: , , , , , , , - Annals of Surgery 2003 cited by 376

  20. Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , - Annals of Surgery 2015 cited by 117

  21. Revisiting Liver Anatomy and Terminology of Hepatectomies

    Authors: - Annals of Surgery 2013 cited by 95

  22. Ideal Surgical Margin to Prevent Early Recurrence After Hepatic Resection for Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , - World Journal of Surgery 2021 cited by 35

  23. Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients

    Authors: , , , , , - Annals of Surgery 1993 cited by 871

  24. Is Liver Resection Justified for Patients With Hepatic Metastases From Breast Cancer?

    Authors: , , , , , , , , , - Annals of Surgery 2006 cited by 382